Mustang Bio (MBIO) EBIT Margin (2018)
Mustang Bio (MBIO) posted quarterly EBIT Margin of 12954.0% for Q1 2018.
Mustang Bio (MBIO) EBIT Margin (2018) Analysis & Trends
Mustang Bio (MBIO) has reported EBIT Margin for 1 consecutive years, with 12954.0% the latest figure, recorded in Q1 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.93 Bn | 131.07 Bn | 2.84 Bn | 37.40% |
| 2 | Regeneron Pharmaceuticals | 85.91 Bn | 77.92 Bn | 3.93 Bn | 30.15% |
| 3 | Argenx Se | 64.98 Bn | 59.80 Bn | 1.37 Bn | 32.54% |
| 4 | Moderna | 58.86 Bn | 53.72 Bn | 52.00 Mn | -562.07% |
| 5 | BeOne Medicines | 42.03 Bn | 36.93 Bn | 1.53 Bn | 19.06% |
| 6 | Alnylam Pharmaceuticals | 31.54 Bn | 28.23 Bn | 992.69 Mn | 17.93% |
| 7 | BioNTech SE | 27.88 Bn | 9.49 Bn | 668.28 Mn | -35.57% |
| 8 | Insmed | 27.44 Bn | 26.28 Bn | 358.27 Mn | -0.36% |
| 9 | Royalty Pharma | 27.35 Bn | 26.51 Bn | - | 19.75% |
| 10 | Mustang Bio | 3.90 Mn | 3.90 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2018 | -12,954.00% |